Comparing different adjuvants for vaccines against flu and certain infections
Adjuvant Comparison and Characterization
This study is looking at how different ingredients that boost vaccine effectiveness can help improve the immune response to flu and certain infections, with the goal of creating better vaccines for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11122157 on NIH RePORTER |
What this research studies
This research investigates how different adjuvants, which are substances that enhance the body's immune response to vaccines, work in combination with vaccines for influenza and infections caused by Chlamydia muridarum and Coxiella burnetii. By comparing these adjuvants side-by-side, the study aims to create detailed immune profiles, known as 'immune fingerprints', that show how effectively each adjuvant stimulates the immune system. This could help in developing more effective vaccines tailored to specific diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for influenza and infections caused by Chlamydia muridarum or Coxiella burnetii.
Not a fit: Patients who are not at risk for these infections or who have already been vaccinated may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines that provide better protection against influenza and certain infectious diseases.
How similar studies have performed: Previous research has shown promise in using adjuvants to enhance vaccine efficacy, indicating that this approach could yield significant advancements.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Felgner, Philip — University of California-Irvine
- Study coordinator: Felgner, Philip
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.